Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artesunate-pyronaridine efficacy and safety study for uncomplicated falciparum malaria in Vietnam
ACTRN12621001743853Phase 4Recruiting
- Sponsor
- World Health Organization
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of pyronaridine and chloroquine in Malaria and malaria (2 arms), sponsored by World Health Organization. Primary endpoints: Day 42 PCR-corrected adequate clinical and parasitological response, Adverse events and serious adverse events and 1 more. Started Oct 2021; status: recruiting.
02
Drugs
pyronaridinechloroquine
03
Conditions
Malariamalaria
Beyond the preview
Go deeper on ACTRN12621001743853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621001743853.